3B Future Health Fund is an investment fund dedicated to supporting early-stage, innovative healthcare companies in the US, Europe, and Israel, primarily in oncology and rare diseases. The fund seeks companies with potential first-in-class assets, revolutionary insights, experienced management teams, and strong investor syndicates. Initial investments are typically made during Series A rounds, with some cases even earlier. The fund aims to build a diversified portfolio of 10-15 companies, investing up to $12 million in each, and often seeks board positions. Capital is reserved for follow-on rounds, with a typical investment horizon of five to eight years, or shorter if value inflection points permit earlier exits.
Is 3B Future Health Fund the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with 3B Future Health Fund, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Seed, Series A
First ticket size
€100,000 - €12,000,000
When approaching 3B Future Health Fund, founders should highlight the scientific novelty and clinical differentiation of their solution, especially if it addresses significant unmet needs in oncology or rare diseases. Demonstrate a clear path to value inflection points and articulate how your team’s expertise and syndicate strength can accelerate development. Be prepared to discuss your strategy for regulatory milestones and how you plan to leverage board-level support to drive growth and de-risk the business.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.